SYRA · Syra Health Corp. Class A
What's happening
- SYRA is down 14.85% today, trading at $0.11. — Live quote
- Volume today (2,577) is well below its 3-month average of 38,610. (Finnhub fundamentals)
- Reports earnings on 2026-11-10, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS beat estimates: $-0.06 actual vs. $-0.21 estimated (+72.0%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Performance Overview (Trailing returns vs S&P 500 benchmark)
Earnings Trends (Quarterly EPS Actual vs Estimate)
Valuation Measures & Ratios
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | — | $1.3M | $1.3M | $704.0K | $3.1M |
| P/E | — | -2.56 | -1.06 | -0.30 | -0.82 |
| Price/Sales | — | 0.17 | 0.16 | 0.09 | 0.39 |
| Price/Book | — | 0.56 | 0.57 | 0.29 | 1.25 |
| EV/Revenue | — | -0.20 | -0.09 | -0.20 | 0.07 |
| ROE | — | -22.04% | -53.38% | -97.08% | -151.72% |
| ROA | — | -13.20% | -36.14% | -67.51% | -100.12% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Revenue growth is 23.0% on the provider's reported measure. Finnhub fundamentals ↗
- Latest SEC filing is Form 4, filed 2026-09-02; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Net profit margin is 1.6%. Finnhub fundamentals ↗
- Trailing P/E is 90.1, a high price relative to reported earnings. Finnhub fundamentals ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on SYRA
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.4M | $2.3M | $1.7M | $1.9M | $1.9M | $2.3M | $2.0M | $1.8M |
| Gross profit | $1.1M | $971.3K | $554.5K | $752.9K | $589.2K | $668.3K | $350.0K | $299.8K |
| Operating income | $251.6K | $191.0K | -$232.2K | -$63.2K | -$473.3K | -$428.9K | -$1.4M | -$1.4M |
| Net income | $250.2K | $241.0K | -$225.9K | -$63.6K | -$472.3K | -$417.5K | -$1.4M | -$1.4M |
| EPS (diluted) | $0.02 | $0.02 | $-0.02 | $-0.01 | $-0.04 | $-0.06 | $-0.21 | $-0.22 |
| EPS (basic) | $0.02 | $0.02 | $-0.02 | $-0.01 | $-0.04 | $-0.06 | $-0.21 | $-0.22 |
| Operating margin | $11 | $8 | -$14 | -$3 | -$25 | -$19 | -$71 | -$82 |
| Net margin | $10 | $11 | -$13 | -$3 | -$25 | -$19 | -$71 | -$83 |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $3.8M | $3.9M | $2.8M | $3.3M | $3.5M | $3.7M | $3.7M | $4.4M |
| Total liabilities | $1.2M | $1.6M | $674.7K | $1.1M | $1.1M | $1.3M | $800.8K | $1.1M |
| Stockholders' equity | $2.6M | $2.4M | $2.1M | $2.2M | $2.4M | $2.5M | $2.9M | $3.3M |
| Total current assets | $3.7M | $3.9M | $2.7M | $3.2M | $3.4M | $3.6M | $3.4M | $4.1M |
| Total current liabilities | $1.2M | $1.6M | $674.7K | $1.1M | $1.1M | $1.3M | $613.5K | $877.8K |
| Cash & equivalents | $2.1M | $2.9M | $1.6M | $2.0M | $2.3M | $2.5M | $2.4M | — |
| Accounts receivable | $1.5M | $869.1K | $918.4K | $926.3K | $886.4K | — | $680.8K | — |
| Other current assets | $153.4K | $136.1K | $205.4K | $307.8K | $242.4K | $210.8K | $276.6K | $483.0K |
| Property, plant & equipment | $5.2K | $5.9K | $7.0K | $9.2K | $14.6K | $20.6K | $27.3K | $34.6K |
| Accounts payable | — | — | — | — | $557.1K | $325.0K | $101.7K | $212.9K |
| Accrued liabilities | $220.3K | $293.5K | $194.8K | $224.7K | $124.8K | $211.9K | $230.4K | $309.6K |
| Deferred revenue (current) | $505.9K | $750.5K | $16.6K | $141.6K | $266.6K | $599.2K | $16.6K | $6.1K |
| Retained earnings | -$9.2M | -$9.5M | -$9.7M | -$9.6M | -$9.4M | -$9.3M | -$8.8M | -$8.3M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$718.8K | $1.4M | -$289.2K | -$244.3K | -$72.5K | $158.2K | -$214.7K | -$413.3K |
| Investing cash flow | — | — | -$107 | — | — | — | $0 | $0 |
| Financing cash flow | -$79.8K | -$54.4K | -$72.5K | -$85.1K | -$112.2K | -$63.1K | -$87.3K | $1.5M |
| Free cash flow | — | — | -$289.3K | — | — | — | -$214.7K | -$413.3K |
| Capital expenditures | — | — | $107 | — | — | — | $0 | $0 |
| Share-based compensation | $21.1K | $23.3K | $23.4K | $21.1K | $21.1K | $32.9K | $31.3K | $0 |
| Change in accounts receivable | $600.9K | -$49.2K | $32.0K | — | -$59.5K | $265.0K | -$203.6K | $94.3K |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Revenue | $7.2M | $8.0M | $5.5M | $5.6M |
| Gross profit | $2.5M | $1.7M | $1.4M | $1.1M |
| Operating income | -$904.3K | -$3.8M | -$2.9M | -$2.1M |
| Net income | -$896.3K | -$3.8M | -$2.9M | -$2.1M |
| EPS (diluted) | $-0.08 | $-0.50 | $-0.60 | $-0.70 |
| EPS (basic) | $-0.08 | $-0.50 | $-0.60 | $-0.70 |
| Operating margin | -$13 | -$47 | -$52 | -$37 |
| Net margin | -$12 | -$47 | -$53 | -$38 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $2.8M | $3.7M | $4.9M | $2.3M | — |
| Total liabilities | $674.7K | $800.8K | $910.1K | $1.6M | — |
| Stockholders' equity | $2.1M | $2.9M | $4.0M | $710.1K | -$7.1K |
| Total current assets | $2.7M | $3.4M | $4.8M | $1.4M | — |
| Total current liabilities | $674.7K | $613.5K | $910.1K | $1.5M | — |
| Cash & equivalents | $1.6M | $2.4M | $3.3M | — | — |
| Accounts receivable | $918.4K | $680.8K | — | — | — |
| Other current assets | $205.4K | $276.6K | $389.8K | $222.3K | — |
| Property, plant & equipment | $7.0K | $27.3K | $79.0K | $112.5K | — |
| Accounts payable | — | $101.7K | $463.0K | — | — |
| Accrued liabilities | $194.8K | $230.4K | $199.0K | $239.1K | — |
| Deferred revenue (current) | $16.6K | $16.6K | — | — | — |
| Retained earnings | -$9.7M | -$8.8M | -$5.1M | -$2.1M | — |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 |
|---|---|---|---|---|
| Operating cash flow | -$447.7K | -$2.9M | -$2.8M | -$2.2M |
| Investing cash flow | -$107 | -$11.1K | -$15.3K | -$121.3K |
| Financing cash flow | -$332.8K | $2.1M | $6.1M | $2.3M |
| Free cash flow | -$447.9K | -$2.9M | -$2.8M | -$2.4M |
| Capital expenditures | $107 | $11.1K | $15.3K | $121.3K |
| Share-based compensation | $98.6K | $59.8K | $32.8K | $2.9K |
| Change in accounts receivable | $237.5K | -$379.8K | $59.5K | $940.5K |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding SYRA as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2023-09-29 to 2026-01-05
Recent transactions
- Most recent: Alexander Gregory R. (CEO) — Grant / award of 110,537 shares on 2026-01-05.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Alexander Gregory R. | CEO | Grant / award | 2026-01-05 | 110,537 |
| Prasad Priya | CFO and COO | Open market purchase | 2024-09-12 | 5,303 |
| Allam Sandeep | President and Chair | Open market purchase | 2023-12-14 | 294 |
| Syed Feroz | 10% owner | Open market purchase | 2023-12-14 | 175 |
| Vuppalanchi Deepika | CEO | Open market purchase | 2023-12-04 | 426 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-01-05 | Alexander Gregory R. | CEO | Grant / award | 110,537 | $0.00 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-22 05:15 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-09-02 | 4 | 2026-08-31 | View on SEC.gov → |
| 2026-08-14 | 4 | 2026-08-11 | View on SEC.gov → |
| 2026-08-11 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-11 | 8-K | 2026-08-11 | View on SEC.gov → |
| 2026-07-23 | 8-K | 2026-07-23 | View on SEC.gov → |
| 2026-05-07 | 10-Q | 2026-03-31 | View on SEC.gov → |
| 2026-05-07 | 8-K | 2026-05-07 | View on SEC.gov → |
| 2026-03-12 | 10-K | 2025-12-31 | View on SEC.gov → |
| 2026-03-12 | 8-K | 2026-03-12 | View on SEC.gov → |
| 2026-02-03 | 4 | 2026-01-05 | View on SEC.gov → |
| 2025-12-18 | 8-K | 2025-12-15 | View on SEC.gov → |
| 2025-11-25 | 4 | 2025-11-21 | View on SEC.gov → |
Recent news
Headlines about SYRA (Syra Health Corp. Class A). Links open the publisher — we don’t host full articles.
-
SYRA S-8 & SEC Filings
Yahoo! Finance Canada · 2026-10-17 -
Syra Health Awarded Three-Year Public Health Analytics Contract with Mississippi State Department of Health
Yahoo Finance · 2026-09-29 -
Syra Health, in Partnership with HealthSync, Selected for CMS ACCESS Model, Advancing Long-Term Growth Strategy
Yahoo Finance · 2026-09-03 -
Syra Health, Wake County Public Health Expand Wellness Partnership
Yahoo Finance · 2026-09-01 -
Syra Health Achieves 23% Revenue Growth, Improves Gross Margin to 44.5% in Second Consecutive Profitable Quarter
Yahoo Finance · 2026-08-11 -
Syra Health To Announce Second Quarter 2026 Financial Results
Yahoo Finance · 2026-08-04 -
Syra Health Appoints Dr. Cori McMahon as Chief Medical Officer to Support its Growth Strategy
Yahoo Finance · 2026-07-07 -
Syra Health GAAP EPS of $0.02, revenue of $2.3M
Seeking Alpha · 2026-05-07
No headlines in this category right now — try “All”.